Only 40 percent say they will take part in first round of Israel vaccine rollout

The latest Jewish News

Read this week’s digital edition

Click Here

Only 40 percent say they will take part in first round of Israel vaccine rollout

With national Covid-19 vaccination campaign beginning next week, a survey suggests only two fifths of the nation are prepared to get the jab

Covid vaccine
Covid vaccine

As Jerusalem prepares for the planned rollout of its national COVID-19 vaccination campaign next week, Israeli health officials are grappling with how to convince a largely skeptical population to receive shots whose rapid development has raised concerns over the possibility of side effects.

Israel has ordered millions of doses of the vaccine, which were jointly developed by the pharmaceutical firms Pfizer and BioNTech in less than a year — far shorter than the usual decade-long process — and relied on novel techniques not commonly used in the industry. But while clinical human testing has found the vaccine to be over 90% effective and it has already begun being administered in the United States and United Kingdom, many around the world have expressed significant reservations.

In a poll released last month by the Israel Democracy Institute, a Jerusalem think tank, only around 40% of Israelis said they would agree to participate in the first round of vaccinations while more than half would not. Only 21% of the general public said they were convinced that they would agree to be part of the first group to receive the vaccination, with another 18.7% saying they thought they would agree, showing less certainty.

Arab Israelis and women were found to be less likely than their Jewish and male counterparts to accept a vaccination.

Most Israelis believe in vaccines. Dr. Or Anabi, one of the researchers behind the Israel Democracy Institute survey, said their skepticism about this one is grounded in understandable concerns.

“People are afraid that because the vaccine hasn’t been tested for as long as other vaccines that were developed in the past that maybe we don’t know everything about the long-term effects,” Anabi explained.

Such concerns are not limited to Israel. While Americans have shown an increasing willingness to be inoculated, there remains significant skepticism in a number of European countries.

The institute’s numbers track with a similar poll conducted recently by Haifa University, which found that 20.3% of Jewish-Israeli respondents and 16% of Arab-Israeli respondents said they would “like the vaccine immediately.”

The Haifa survey, conducted by Manfred Green, director of the university’s international master’s program in public health, found that “7.7 percent of Jewish men, 29.4 percent of Arab men, 17.2 percent of Jewish women, and 41.2 percent of Arab women would refuse the vaccine under any circumstances,” highlighting “a striking lack of trust in a large part of the whole Israeli population.”

However, once the vaccination campaign gets underway and “thousands have received it,” skepticism will recede and the number of people willing to receive the vaccine “will increase significantly,” Green told the Jewish Telegraphic Agency, citing a figure of 58.6% of Jewish Israelis willing to be immunised as the program rolls out.

One Israel reached 60-70% coverage, it will begin to reach herd immunity and “we can see how we can return to normal life,” Nadav Davidovitch, who heads Ben-Gurion University’s School of Public Health, told JTA.

“I see actually a process where more information is becoming transparent and more efficient explanations being given by experts, so suspicion is getting lower, although it’s clear that some very radical anti-vax groups are trying to promote fake news,” he said.

According to Davidovitch, it is especially important to convince frontline medical personnel to receive the vaccine in order to serve as an example to the wider public. The Ministry of Health, the Israeli Medical Association and other groups are working on an informational awareness campaign via both traditional and social media intended to promote inoculation.

On Tuesday morning, following days of talks with Israeli health officials, several leading Charedi rabbis endorsed the use of newly developed COVID-19 vaccines ahead of the government’s planned nationwide rollout, signalling that the efforts may be bearing fruit.

The Charedi, or ultra-Orthodox, community was one of the hardest hit during the pandemic. According to Israeli health officials, Charedi communities have accounted for at least 34% of cases despite comprising just 12% of the total population.

While Charedim trust their rabbinic leadership more than health authorities, the number of them who are reluctant to take the vaccine doesn’t appear to be significantly greater than the general population, although it is higher than average. About 40% of Charedi Jews replied that they were sure that they wouldn’t agree to be vaccinated during the first round versus 32% among national religious Jews and 24% among secular.

Regarding the “vaccine the differences are not significant,” the researcher Anabi said.

As for Davidovitch, he believes that herd immunity is attainable and that “as many people will show an example and get vaccinated … more people will join in.”

Support your Jewish community. Support your Jewish News

Thank you for helping to make Jewish News the leading source of news and opinion for the UK Jewish community. Today we're asking for your invaluable help to continue putting our community first in everything we do.

Unlike other Jewish media, we do not charge for content. That won’t change. Because we are free, we rely on advertising to cover our costs. This vital lifeline, which has dropped in recent years, has fallen further due to coronavirus.

For as little as £5 a month you can help sustain the vital work we do in celebrating and standing up for Jewish life in Britain.

Jewish News holds our community together and keeps us connected. Like a synagogue, it’s where people turn to feel part of something bigger. It also proudly shows the rest of Britain the vibrancy and rich culture of modern Jewish life.

You can make a quick and easy one-off or monthly contribution of £5, £10, £20 or any other sum you’re comfortable with.

100% of your donation will help us continue celebrating our community, in all its dynamic diversity...


Being a community platform means so much more than producing a newspaper and website. One of our proudest roles is media partnering with our invaluable charities to amplify the outstanding work they do to help us all.


There’s no shortage of oys in the world but Jewish News takes every opportunity to celebrate the joys too, through projects like Night of Heroes, 40 Under 40 and other compelling countdowns that make the community kvell with pride.


In the first collaboration between media outlets from different faiths, Jewish News worked with British Muslim TV and Church Times to produce a list of young activists leading the way on interfaith understanding.


Royal Mail issued a stamp honouring Holocaust hero Sir Nicholas Winton after a Jewish News campaign attracted more than 100,000 backers. Jewish News also produces special editions of the paper highlighting pressing issues including mental health and Holocaust remembrance.

Easy access

In an age when news is readily accessible, Jewish News provides high-quality content free online and offline, removing any financial barriers to connecting people.

Voice of our community to wider society

The Jewish News team regularly appears on TV, radio and on the pages of the national press to comment on stories about the Jewish community. Easy access to the paper on the streets of London also means Jewish News provides an invaluable window into the community for the country at large.

We hope you agree all this is worth preserving.

read more: